Aramouni Karl, Assaf Roland K, Azar Maria, Jabbour Karen, Shaito Abdullah, Sahebkar Amirhossein, Eid Assaad A, Rizzo Manfredi, Eid Ali H
Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Biomedical Research Center, Department of Biomedical Sciences at College of Health Sciences, College of Medicine, Qatar University, Doha, Qatar.
Front Pharmacol. 2023 Oct 13;14:1285754. doi: 10.3389/fphar.2023.1285754. eCollection 2023.
Atherosclerosis is a major instigator of cardiovascular disease (CVD) and a main cause of global morbidity and mortality. The high prevalence of CVD calls for urgent attention to possible preventive measures in order to curb its incidence. Traditional risk factors of atherosclerosis, like age, smoking, diabetes mellitus, dyslipidemia, hypertension and chronic inflammation, are under extensive investigation. However, these only account for around 50% of the etiology of atherosclerosis, mandating a search for different or overlooked risk factors. In this regard, chronic infections, by for instance, are a primary candidate. colonizes the gut and contributes to several gastrointestinal diseases, but, recently, the potential involvement of this bacterium in extra-gastric diseases including CVD has been under the spotlight. Indeed, infection appears to stimulate foam cell formation as well as chronic immune responses that could upregulate key inflammatory mediators including cytokines, C-reactive protein, and lipoproteins. These factors are involved in the thickening of intima-media of carotid arteries (CIMT), a hallmark of atherosclerosis. Interestingly, infection was found to increase (CIMT), which along with other evidence, could implicate in the pathogenesis of atherosclerosis. Nevertheless, the involvement of in CVD and atherosclerosis remains controversial as several studies report no connection between and atherosclerosis. This review examines and critically discusses the evidence that argues for a potential role of this bacterium in atherogenesis. However, additional basic and clinical research studies are warranted to convincingly establish the association between and atherosclerosis.
动脉粥样硬化是心血管疾病(CVD)的主要诱因,也是全球发病和死亡的主要原因。CVD的高患病率要求我们迫切关注可能的预防措施,以控制其发病率。动脉粥样硬化的传统危险因素,如年龄、吸烟、糖尿病、血脂异常、高血压和慢性炎症,正在受到广泛研究。然而,这些因素仅占动脉粥样硬化病因的约50%,因此需要寻找不同的或被忽视的危险因素。在这方面,例如慢性感染就是一个主要候选因素。[细菌名称]定殖于肠道并导致多种胃肠道疾病,但最近,这种细菌在包括CVD在内的胃外疾病中的潜在作用受到了关注。事实上,[细菌名称]感染似乎会刺激泡沫细胞形成以及慢性免疫反应,从而上调包括细胞因子、C反应蛋白和脂蛋白在内的关键炎症介质。这些因素与颈动脉内膜中层厚度(CIMT)增加有关,CIMT增加是动脉粥样硬化的一个标志。有趣的是,发现[细菌名称]感染会增加CIMT,这与其他证据一起,可能表明[细菌名称]参与了动脉粥样硬化的发病机制。然而,[细菌名称]在CVD和动脉粥样硬化中的作用仍存在争议,因为一些研究报告称[细菌名称]与动脉粥样硬化之间没有关联。本综述审视并批判性地讨论了支持这种细菌在动脉粥样硬化发生中可能起作用的证据。然而,还需要更多的基础和临床研究来令人信服地确定[细菌名称]与动脉粥样硬化之间的关联。